Keyword
    advanced

The Deming Approach to Quality. Fall 07

By John H. Van Drie
We explore the relevance to pharmaceutical research of the ideas of W. Edwards Deming, the statistician whose ideas on quality transformed the manufacturing sector of post-war Japan.
Read more...

Global deal-making – the ‘PITCH’. Fall 2003

By Dr Paul Charlton
The age-old adage that your product is only as good as the person selling it still holds true in today’s highly competitive pharmaceutical environment.Yet basic presentation skills are,...
Read more...

Technology, Bane or Bonanza for the Pharmaceutical industry? Fall 07

By Dr Stephen Naylor, Adam W. Culbertson and Dr Stephen J. Valentine
Productivity in the pharmaceutical industry has long held well-documented concerns. While the adoption of new technologies into the drug discovery and development process has often been s...
Read more...

Building Innovative Partnerships in Neglected Disease Research. Winter 06

By Prof Paul Herrling
While the recent biomedical revolution has given rise to significant advances in medical treatment, many neglected diseases that are endemic in underdeveloped parts of the world remain un...
Read more...

NEWS and the drug discovery industry. Summer 03

By Dr Richard Franklin
The use of the PR industry to promote all facets of the pharmaceutical industry is on the increase.We take a brief look at the various uses of PR and the sectors that are being promoted.
Read more...

Repositionings Role in Drug Discovery and Development. Winter 06

By Dr Louis A. Tartaglia and Dr Lee E. Babiss
The large number of drug candidate failures in recent years has been enormously costly for the pharmaceutical industry, but has also created the tremendous opportunity of repositioning th...
Read more...

Implementing and Operating Large Complex Capital Projects in a Research Environment. Winter 06

By Dr Tim Peakman
UK Biobank is a major UK study that will recruit 500,000 volunteers aged between 40 and 69 to provide a resource to study the link between genetic factors, environment and lifestyle in th... Read more...

Green fingers, molecular pathology and the art of drug design. Summer 03

By Dr Keith McCullagh
The current explosion of interest in sophisticated genomic technologies, computerised robotics and high throughput screening of diverse molecular libraries appears to have been associated... Read more...

The biomedical ecosystem delivering better health and prosperity. Fall 06

By Dr Peter B. Corr
The overall message is simple: biomedical innovation – and the public policies and new technologies that sustain and advance innovation – are crucial to the future of biomedical scien... Read more...

The timetable of Invention. Summer 06

By Dr William Bains
The most critical question to any investor in new technology should not be whether a technology will work. Technologies nearly always work in the end, providing they do not break fundamen... Read more...

Whither Pharma? Summer 06

By Dr Alpheus Bingham
It has been suggested that the blockbuster business model, which has been the key to big pharma success, is now broken and completely beyond repair. In a truly global and fast changing bu... Read more...